1. Final report on pharmaceutical cGMPs for the 21st centuryA risk—based approach;Food and Drug Administration,2004
2. Food and Drug Adminstration. Quality by Design for ANDAs: An example for immediaterelease dosage forms;Food and Drug Administration,2012
3. Pharmaceutical Quality by Design: Product and process development, understanding, and control;Yu;Pharm Res,2008
4. Functionality and performance of excipients in a quality-by-design world part 2: Excipient variability, QbD and robust formulations;Moreton;Am Pharm Rev,2009
5. Compendial standards and excipient performance in the QbD era: USP excipient performance chapter <1059>;Sheehan;Am Pharm Rev,2011